ADAM33 gene and environment interactions in developing lungs and their involvement in the early life origin of asthma
ADAM33 gene and environment interactions in developing lungs and their involvement in the early life origin of asthma
批准号:
G0802804/1
负责人:
Hans Haitchi
金额:
$131.9万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Asthma is a common disease affecting both adults and children. It causes wheeziness, chesttightness and cough and is often triggered by exposure to allergens (eg. dust or animal fur). As aresult, the airways contract too much and too easily, limiting airflow into the lung. Asthma tends torun in families suggesting there are ‘asthma’ genes. ADAM33 is such a gene where small changeshave been found in people with asthma and in young children at risk of asthma. It is found inspecialized airway ‘smooth muscle’ cells (ASMCs) that cause airway ‘twitchiness’ in asthma and it isreleased in fluid that is present in the airways of asthmatic patients. In baby lungs, I have foundthat ADAM33 occurs in stem cells that give rise to ASMCs. Therefore, the objectives of my researchare to study the role of ADAM33 in airway development and to understand whether release ofADAM33 can give rise to abnormal ASMC development that might lead to asthma. I will alsoinvestigate whether, and how maternal allergy, a factor that predisposes babies for asthma, affectsADAM33 in ASMC. These studies should help devise new treatments for asthma close to the origin ofthe disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical efficacy and safety studies of ADAM33 oligonucleotides as new disease-modifying asthma therapy
-
批准号:MR/X013960/1
-
项目类别:Research Grant
-
资助金额:$151.65万
-
财政年份:2023
-
负责人:Hans Haitchi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位: